Inside informationEnglish
Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 20/06/2025, 07:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 113834_20250620